Advanced search
Publication Cover
Hematology Volume 18, 2013 - Issue 3
Submit an article Journal homepage
2,569
Views
11
CrossRef citations to date
0
Altmetric
TREATMENT EFFECTS

Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis

Francesco FrattiniDepartment of Hematology and Transfusion MedicineAzienda Ospedaliera, Mantova, ItalyCorrespondence[email protected]
,
Silvia CrestaniDepartment of Hematology and Transfusion MedicineAzienda Ospedaliera, Mantova, Italy
,
Pier Paolo VescoviDepartment of Internal MedicineAzienda Ospedaliera, Mantova, Italy
&
Massimo FranchiniDepartment of Hematology and Transfusion MedicineAzienda Ospedaliera, Mantova, Italy
Pages 181-182 | Published online: 18 Jul 2013

References

  • Seetman S. Martindale: the complete drug reference (electronic version). 34th ed. London: Pharmaceutical Press; 2004.
  • Loftus EV, Kane SV, Bjorkman D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2004;18:179–89.
  • Wyatt S, Joyner MV, Daneshmend TK. Filgrastim for mesalazine-associated neutropenia. Lancet 1993;341:1476.
  • Casellas F, Vallano A, Malagelada JR. Leukopenia and thrombocytopenia as adverese effects of treatment with 5-aminosalicylic suppositories. J Clin Gastroenterol. 1996;22:160–61.
  • Abbuui ZH, Marsh JCW, Smith-Laing G, Gordon-Smith EC. Fatal aplastic anemia after mesalazine. Lancet 1994;343:542.
  • Laidlaw ST, Reilly JT. Antilymphocyte globulin for mesalazine-associated aplastic anemia. Lancet 1994;343:981–2.
  • Kotanagi H, Ito M, Koyama K, Chiba M. Pancytopenia associated with 5-aminosalicylic acid use in a patient with Crohn's disease. J Gastroenterol. 1998;33:571–4.
  • Daneshmend TK. Mesalazine-associated thrombocytopenia. Lancet 1991;15:176–81.
  • Bhidayasiri R, Katz JA. Correction of mesalazine-induced neutropenia with high dose G-CSF. Am J Gastroenterol. 2000;95:3321–2.
  • Jick H, Wald M, Dean AD. The risk of sulfalasazine-ad mesalazine-associated blood disorders. Pharmacotherapy 1995;15:176–81.
  • Fowler BT, Gupta T, Bilal M. Asacol®-induced neutropenia resolution without the use of granulocyte colony-stimulating factor. South Med J. 2010;103:1167–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.